Author:
Moet Gary J.,Watters Amy A.,Sader Helio S.,Jones Ronald N.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference19 articles.
1. Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin–tazobactam;Bradford;Antimicrob. Agents Chemother.,1993
2. M07-A8. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard;Clinical and Laboratory Standards Institute (CLSI),2009
3. Performance standards for antimicrobial susceptibility testing: 19th information supplement (M100-S19);Clinical and Laboratory Standards Institute (CLSI),2009
4. In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin;Fujimura;Int. J. Antimicrob. Agents,2008
5. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830);Jones;Diagn. Microbiol. Infect. Dis.,1989
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献